Suchergebnisse - "Chew, Lee Ping"

PubPharm (3)

1

Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA) : a double-blind, randomised, phase 3 trial

enthalten in: The Lancet. Haematology | 2023

von Lee, J. | Griffin, M. | Kim, J. | +67

2

Long-term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria : 2-year results from two pivotal phase 3 studies

enthalten in: European journal of haematology | 2022

von Kulasekararaj, A. | Griffin, M. | Langemeijer, S. | +109

3

A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia

enthalten in: The New England journal of medicine | 2020

von Cappellini, M. | Viprakasit, V. | Taher, A. | +138

1
[1]